I am working on advancing rapid molecular diagnostics: Genomtec ID POCT system, OncoSNAAT liquid-biopsy oncology testing, and AI-assisted isothermal assay design to make precise nucleic-acid testing faster, simpler and closer to the patient.

We seek strategic partners, investors and commercial collaborators to accelerate Genomtec’s INAAT/SNAAT® platforms through co-development, licensing, manufacturing scale-up, market access and DTC/POCT commercialization across infectious disease, oncology and molecular testing.